Maria Grazia Di Benedetto

Dr. Maria Grazia Di Benedetto

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
MBMaria Grazia Di Benedetto
Maria Grazia Di Benedetto
CBChiara Bottanelli
Chiara Bottanelli
ACAnnamaria Cattaneo
Annamaria Cattaneo
CPCarmine Maria Pariante
Carmine Maria Pariante
ABAlessandra Borsini
Alessandra Borsini

22 November 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
PGPatrizia Genini
Patrizia Genini
IDIlari D’Aprile
Ilari D’Aprile
GPGiulia Petrillo
Giulia Petrillo
MBMaria Grazia Di Benedetto
Maria Grazia Di Benedetto
VBVeronica Begni
Veronica Begni
ACAnnamaria Cattaneo
Annamaria Cattaneo
Depression is a leading cause of global disability and is increasingly recognized as a multifactorial disorder characterized by fundamental disruptions in neuroplasticity, including diminished hippocampal neurogenesis, impaired synaptic plasticity, and dysregulated stress-response systems. Given the limited efficacy of conventional pharmacological treatments, lifestyle-based interventions—most notably physical exercise—have gained considerable attention for their antidepressant effects, partly mediated by secreted exerkines. Among these, adiponectin has emerged as a particularly compelling candidate linking metabolic regulation to neuroplasticity and mood. Recent evidence suggests that adiponectin contributes to the antidepressant effects of exercise by modulating hippocampal neurogenesis, neuroinflammation, and brain-derived neurotrophic factor (BDNF) signalling. Despite these advances, the mechanisms by which adiponectin influences depression remain incompletely understood. This review synthesizes current knowledge on adiponectin’s role in depression pathophysiology, with emphasis on its capacity to enhance neuroplasticity and hippocampal neurogenesis, and its potential to mediate exercise-induced antidepressant effects via defined molecular pathways. Building on these insights, we discuss adiponectin’s translational promise as both a predictive biomarker of treatment response and a novel therapeutic target. By integrating preclinical and clinical evidence, this review offers a comprehensive perspective on adiponectin’s involvement in depression while identifying critical gaps to guide future mechanistic research.

29 August 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
FCFLORIANA DE CILLIS
FLORIANA DE CILLIS
GPGiulia Petrillo
Giulia Petrillo
IDIlari D’Aprile
Ilari D’Aprile
MMMoira Marizzoni
Moira Marizzoni
SSSaleri Samantha
Saleri Samantha
ACAnnamaria Cattaneo
Annamaria Cattaneo
Background: The gut microbiota and the gut epithelium play a central role in maintaining systemic and brain homeostasis from early life. Stressful experiences during sensitive developmental windows can disrupt this balance, increasing long-term susceptibility to psychiatric disorders. However, the mechanisms through which early-life alterations in the microbiota influence brain development and function remain poorly understood. Here, the sex-specific impact of prenatal stress (PNS) on gut integrity and microbial composition in adult offspring was explored. Methods: Thirty dams were mated and randomly assigned to PNS or control. Offspring microbiota was analysed through 16S rRNA sequencing, intestinal morphology with morphometric analyses, and tight junctions using qPCR and immunofluorescence. Results: Exposure to PNS was associated with reduced intestinal surface area in males and shortened crypts in females. In both sexes, PNS caused a decrease in the expression of ZO-1, suggesting impaired gut barrier integrity. 16S rRNA sequencing revealed, furthermore, that PNS exposure was associated with a decrease in beneficial genera, including Akkermansia in males and Clostridia vadinBB60 in females, along with an increase in the pro-inflammatory genus Anaerotruncus, regardless of sex. Notably, some of these alterations were more pronounced in PNS-exposed animals that showed impaired sociability, highlighting gut microbiota inter-individual variability in the response to early-life adversity. Moreover, selected microbial changes show significant correlations with the behavioural outcomes, as well as with intestinal morphology or brain inflammatory markers. Conclusions: Together, these findings pinpoint the gut as a central player in stress vulnerability and highlight specific microbial signatures as promising biomarkers and therapeutic targets for stress-related disorders.

29 August 2026 in Brain, Behavior, & Immunity - Health
Verified
Journal Article
Open access
TPTiziano Prodi
Tiziano Prodi
MRMelissa Rosa
Melissa Rosa
MSMarta Spinoni
Marta Spinoni
CSClaudio Singh Solorzano
Claudio Singh Solorzano
MBMaria Grazia Di Benedetto
Maria Grazia Di Benedetto
ACAnnamaria Cattaneo
Annamaria Cattaneo

3 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
PGPatrizia Genini
Patrizia Genini
IDIlari D’Aprile
Ilari D’Aprile
GPGiulia Petrillo
Giulia Petrillo
MBMaria Grazia Di Benedetto
Maria Grazia Di Benedetto
VBVeronica Begni
Veronica Begni
ACAnnamaria Cattaneo
Annamaria Cattaneo
Depression is a leading cause of global disability and is increasingly recognized as a multifactorial disorder characterized by fundamental disruptions in neuroplasticity, including diminished hippocampal neurogenesis, impaired synaptic plasticity, and dysregulated stress-response systems. Given the limited efficacy of conventional pharmacological treatments, lifestyle-based interventions—most notably physical exercise—have gained considerable attention for their antidepressant effects, partly mediated by secreted exerkines. Among these, adiponectin has emerged as a particularly compelling candidate linking metabolic regulation to neuroplasticity and mood. Recent evidence suggests that adiponectin contributes to the antidepressant effects of exercise by modulating hippocampal neurogenesis, neuroinflammation, and brain-derived neurotrophic factor (BDNF) signalling. Despite these advances, the mechanisms by which adiponectin influences depression remain incompletely understood. This review synthesizes current knowledge on adiponectin’s role in depression pathophysiology, with emphasis on its capacity to enhance neuroplasticity and hippocampal neurogenesis, and its potential to mediate exercise-induced antidepressant effects via defined molecular pathways. Building on these insights, we discuss adiponectin’s translational promise as both a predictive biomarker of treatment response and a novel therapeutic target. By integrating preclinical and clinical evidence, this review offers a comprehensive perspective on adiponectin’s involvement in depression while identifying critical gaps to guide future mechanistic research.

21 September 2026 in Brain, Behavior, & Immunity - Health
Verified
Journal Article
Open access
MBMaria Grazia Di Benedetto
Maria Grazia Di Benedetto
CSClaudio Singh Solorzano
Claudio Singh Solorzano
FGFabio Gamba
Fabio Gamba
ACAnna Casirati
Anna Casirati
MRMelissa Rosa
Melissa Rosa
ACAnnamaria Cattaneo
Annamaria Cattaneo
Antenatal depression is a major public health concern, yet the factors distinguishing clinically manifest symptoms from underlying vulnerability remain poorly understood. This study examined a range of dimensions to identify determinants of antenatal depression and subclinical risk. Two hundred thirty-one pregnant women participating in the PRESeNT cohort study have been stratified as controls (n = 71), at risk of depression during pregnancy (n = 107), or with antenatal depressive symptoms (n = 53). Assessments included psychological measures (depressive symptoms, general and pregnancy-related anxiety, stress exposure and perception, and childhood trauma), along with sociodemographic, relational, health-related, lifestyle, and obstetric variables. Group differences were tested using Kruskal-Wallis and Fisher-Freeman-Halton tests, and correlations among psychological variables were examined using Spearman's rank test. Elastic net penalized logistic regression with cross-validation was applied to identify predictors distinguishing depressed from at-risk women. At-risk and depressed women reported higher levels of depressive symptoms, anxiety, perceived stress, and childhood trauma when compared to controls. Depressed women were more likely to be single, report poorer self-rated health, endorse pre-pregnancy substance use, and have a history of spontaneous miscarriage. In elastic net models distinguishing depressed from at-risk women, higher trait anxiety (OR = 1.11, p = 0.024) and perceived stress (OR = 1.15, p = 0.025) independently predicted depressed status. Antenatal depression appears to be embedded within broader psychological vulnerability during pregnancy. While several relational, obstetric, lifestyle, and trauma-related characteristics were associated with group differences, psychological factors showed the strongest contribution. These findings support the implementation of integrated psychosocial screening during pregnancy to enable earlier identification and preventive care.